(ABT) Abbott’s investigational SIMCOR offers similar LDL lowering to simvastatin and significantly raises HDL and lowers triglycerides in Phase III studies.
(AVGN) Avigen’s AV411 shows promising initial results for neuropathic pain in study.
(AVP) Avon featured positively by Jim Cramer on CNBC’s Mad Money.
(BKC) Burger King $0.35 EPS vs $0.34 est.
(BLDP) Ballard Power confirmed reports that it has been reviewing strategic alternatives with regard to its automotive fuel cell assets due to the lengthy projected timeline to commercialization and high cost of development.
(BSX) Boston Scientific announces sale of Cardiac Surgery and Vascular Surgery businesses for roughly $750 million.
(C) Citigroup’s Chuck Prince is FINALLY out, Rubin named Chairman; Citigroup will take another major writedown; restated Q3 lower to $0.44 vs $0.47 prior.
(CLX) Clorox featured positively by Jim Cramer on CNBC’s Mad Money.
(ECA) EnCana paid $2.55 Billion to acquire the other interest in its Deep Bossier natural gas and land interests.
(ETR) Entergy $2.30 EPS vs $2.17 est.
(F) Ford and UAW reached tentative agreement on new national labor agreement.
(HGSI) Human Genome Sciences showed positive Phase IIb hepatitis C data.
(LLY) Eli Lilly showed its clotting drug works better than Plavix, but more bleeding is a risk.
(MESA) Mesa Air appoints interim CFO.
(MVL) Marvel Enterprises $0.45 EPS vs $0.29 est.; raised guidance; Sees 2008 $1.30-1.50 vs $1.26 est.
(MRK) Merck showed more positive data on GARDASIL.
(NAT) Nordic American Tanker missed earnings after one-time drydocking and repair charges.
(NOVC) NOVACEA halted its ASCENT-2 Phase III trial in its lead product candidate for advanced prostate cancer because of imbalance in deaths in trial arms.
(NUS) Nu Skin $0.26 EPS vs $0.24 est.; lowered next quarter guidance; increases share buyback plan to $100 million.
(OMRI) Omrix Biopharma $0.21 EPS vs $0.13 est; raised sales guidance.
(SYY) Sysco Foods $0.43 EPS vs $0.41 est.
(WCG) WellCare trading up 35% after preliminary results were filed, Jefferies upgrade.
Jon C. Ogg
November 5, 2007
Top Gaining Stocks
Top Losing Stocks